ArticleJournal of education and health promotion2026
Evaluating the effect of using a mobile app on the management of chemotherapy side effects and quality of life in breast cancer patients: Protocol for a randomized controlled trial.
Article in Journal of education and health promotion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis is a protocol to evaluate the impact of using a mobile app on managing chemotherapy side effects and quality of life (QoL) in breast cancer patients. MATERIALS AND
methodA double-arm randomized controlled trial (RCT) with a 1:1 allocation ratio will be conducted with 72 breast cancer patients undergoing chemotherapy at Omid Hospital in Mashhad. Both groups will receive chemotherapy and usual face-to-face visits, while the intervention group will also use the designed mobile app during the study period. The overall health status and QoL of patients in both the intervention and control groups are evaluated before (at the beginning of the participant's third chemotherapy session) and after (at the end of the 4-week intervention period).
resultsIn the first stage, the app's initial content was categorized based on a literature review and guidelines for managing chemotherapy side effects. In the second stage, the created content was included in a focused group meeting with six radiotherapy oncologists and experts in this field. Twenty categories related to side effects during chemotherapy were approved by experts. After the approval of the content, the design and development of the mobile app will be done. Finally, by analyzing and comparing the findings obtained in patients of both groups, we will examine the effect of using the app on the management of side effects and QoL in breast cancer patients undergoing chemotherapy. In addition, the usability of the mobile app will be evaluated from the users' point of view.
conclusionIt is possible to design and develop a mobile app to improve chemotherapy side effects and QoL in breast cancer patients. Although its efficacy still needs further evaluation, we hope it can help improve the side effects of chemotherapy and QoL in breast cancer patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.